EDGAR Filing Documents for 0001171843-15-002575

Form 8-K - Current report:

SEC Accession No. 0001171843-15-002575

Filing Date

2015-05-06

Accepted

2015-05-06 16:00:57

Documents

Period of Report

2015-05-06

Items

Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq	Description	Document	Type	Size
1	FORM 8-K FILING DOCUMENT	document.htm	8-K	6661
2	PRESS RELEASE	newsrelease.htm	EX-99	39581
	Complete submission text file	0001171843-15-002575.txt		47423

Mailing Address 100-8900 GLENLYON PARKWAY BURNABY A1 V5J 5J8

Business Address 100-8900 GLENLYON PARKWAY BURNABY A1 V5J 5J8 604-419-3200

TEKMIRA PHARMACEUTICALS Corp (Filer) CIK: 0001447028 (see all company filings)

IRS No.: 980597776 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-34949 | Film No.: 15836864
SIC: 2834 Pharmaceutical Preparations